<!doctype html>

<html lang="en">
<head>
    <meta charset="utf-8">
    <meta content="IE=edge" http-equiv="X-UA-Compatible">
    <meta content="width=device-width, initial-scale=1.0" name="viewport">
    <title>GA TB Reference Guide </title>
    <meta content="GA TB Reference Guide" name="description">
    <meta content="SitePoint" name="author">
    <link href="../assets/uikit.css" rel="stylesheet">
    <link href="../assets/style.css" rel="stylesheet">

</head>

<body>
<div class="uk-container">
    <div class="chapter-header">
        <div class="header-title">
            <div>
                <img src="ic_chart.svg" width="16" height="16" class="ic_chapter_icon">
            </div>
            <p class="chapter-title">8. First-line TB Drugs: Dosing for Adults (ages 16 and over) Directly Observed Therapy (DOT) is mandatory</p>
        </div>
        <p> <span class="view-in-chapter-highlight"> View in chapter → <span> <a href="5_treatment_of_current_(active)_disease_therapy__c__special_clinical_situations.html#table8"> Special Clinical Situations </a></p>
        <p class="last-updated"><i>Last Updated October 2025</i></p>
    </div>
    <hr>
    <div class="uk-overflow-auto"
         id="table_8_first-line_tb_drugs_dosing_for_adults_(ages_16_and_over)_directly_observed_therapy_(dot)_is_mandatory">
         <div class="uk-tabs-container">
            <ul class="tabs">
                <li><button class="tab-button active-option" onclick="switchTab(0, event)"> Isoniazid</button></li>
                <li><button class="tab-button" onclick="switchTab(1, event)"> Rifampin</button></li>
                <li><button class="tab-button" onclick="switchTab(2, event)"> Rifabutin</button></li>
                <li><button class="tab-button" onclick="switchTab(3, event)"> Pyrazinamide¹</button></li>
                <li><button class="tab-button" onclick="switchTab(4, event)"> Ethambutol¹</button></li>
            </ul>
        </div>

        <div id="content0" class="option-content active-option">
            <table class="uk-table uk-table-small uk-table-divider">
                <tbody>
                    <tr>
                        <th class="uk-table-shrink">Frequency</th>
                        <td>Daily</td>
                        <td>Thrice-Weekly</td>
                    </tr>
                    <tr>
                        <th class="uk-table-shrink">Adult Dose based on body weight in kilograms (kg) <span class="info-icon" data-tooltip="NOTE: Formula used to convert pounds to kilograms: Divide pounds by 2.2 to get kilograms. Example: Patient weighs 154 pounds ÷ 2.2 = 70 kilograms."  data-tooltip-position="tooltip-right">i</span></th>
                        <td>300 mg</td>
                        <td>900 mg</td>
                    </tr>
                    <tr>
                        <th class="uk-table-shrink">Adverse Reactions</th>
                        <td colspan="2">
                            <ul>
                                <li>Gastrointestinal (GI) upset</li>
                                <li>Liver enzyme elevation</li>
                                <li>Hepatitis</li>
                                <li>Mild effects on central nervous</li>
                                <li>Drug interactions</li>
                            </ul>
                        </td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div id="content1" class="option-content">
            <table class="uk-table uk-table-small uk-table-divider">
                <tbody>
                    <tr>
                        <th class="uk-table-shrink">Frequency</th>
                        <td>Daily</td>
                        <td>Thrice-Weekly</td>
                    </tr>
                    <tr>
                        <th class="uk-table-shrink">Adult Dose based on body weight in kilograms (kg) <span class="info-icon" data-tooltip="NOTE: Formula used to convert pounds to kilograms: Divide pounds by 2.2 to get kilograms. Example: Patient weighs 154 pounds ÷ 2.2 = 70 kilograms." data-tooltip-position="tooltip-right">i</span></th>
                        <td>600 mg</td>
                        <td>600 mg</td>
                    </tr>
                    <tr>
                        <th class="uk-table-shrink">Adverse Reactions</th>
                        <td colspan="2">
                            <ul>
                                <li>Orange discoloration of body fluids and secretions</li>
                                <li>Drug interactions</li>
                                <li>GI upset</li>
                                <li>Hepatitis</li>
                                <li>Bleeding problems</li>
                                <li>Influenze-like symptoms</li>
                                <li>Rash</li>
                                <li>Uveitis (rifabutin only)</li>
                            </ul>
                        </td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div id="content2" class="option-content">
            <table class="uk-table uk-table-small uk-table-divider">
                <tbody>
                    <tr>
                        <th class="uk-table-shrink">Frequency</th>
                        <td>Daily</td>
                        <td>Thrice-Weekly</td>
                    </tr>
                    <tr>
                        <th class="uk-table-shrink">Adult Dose based on body weight in kilograms (kg) <span class="info-icon" data-tooltip="NOTE: Formula used to convert pounds to kilograms: Divide pounds by 2.2 to get kilograms. Example: Patient weighs 154 pounds ÷ 2.2 = 70 kilograms." data-tooltip-position="tooltip-right">i</span></th>
                        <td>300 mg</td>
                        <td>Not recommended</td>
                    </tr>
                    <tr>
                        <th class="uk-table-shrink">Adverse Reactions</th>
                        <td colspan="2">
                            <ul>
                                <li>Orange discoloration of body fluids and secretions</li>
                                <li>Drug interactions</li>
                                <li>GI upset</li>
                                <li>Hepatitis</li>
                                <li>Bleeding problems</li>
                                <li>Influenze-like symptoms</li>
                                <li>Rash</li>
                                <li>Uveitis (rifabutin only)</li>
                            </ul>
                        </td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div id="content3" class="option-content">
            <table class="uk-table uk-table-small uk-table-divider">
                <tbody>
                    <tr>
                        <th class="uk-table-shrink">Frequency</th>
                        <td>Daily</td>
                        <td>Thrice-Weekly</td>
                    </tr>
                    <tr>
                        <th rowspan="3" class="uk-table-shrink">Adult Dose based on body weight in kilograms (kg) <span class="info-icon" data-tooltip="NOTE: Formula used to convert pounds to kilograms: Divide pounds by 2.2 to get kilograms.Example: Patient weighs 154 pounds ÷ 2.2 = 70 kilograms." data-tooltip-position="tooltip-right">i</span></th>
                        <td>40-55 kg: 1000 mg</td>
                        <td>40-55 kg: 1500 mg</td>
                        <tr>
                            <td>56-75 kg: 2500 mg</td>
                            <td>56-75 kg: 1500 mg</td>
                        </tr>
                        <tr>
                            <td>76+ kg: 3000 mg</td>
                            <td>76+ kg: 4000 mg</td>
                        </tr>
                    </tr>
                    <tr>
                        <th class="uk-table-shrink">Adverse Reactions</th>
                        <td colspan="2">
                            <ul>
                                <li>GI upset</li>
                                <li>Joint aches</li>
                                <li>Hepatitis</li>
                                <li>Rash</li>
                                <li>Hyperuricemia</li>
                                <li>Gout (rare)</li>
                            </ul>
                        </td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div id="content4" class="option-content">
            <table class="uk-table uk-table-small uk-table-divider">
                <tbody>
                    <tr>
                        <th class="uk-table-shrink">Frequency</th>
                        <td>Daily</td>
                        <td>Thrice-Weekly</td>
                    </tr>
                    <tr>
                        <th rowspan="3" class="uk-table-shrink">Adult Dose based on body weight in kilograms (kg) <span class="info-icon" data-tooltip="NOTE: Formula used to convert pounds to kilograms: Divide pounds by 2.2 to get kilograms. Example: Patient weighs 154 pounds ÷ 2.2 = 70 kilograms." data-tooltip-position="tooltip-right">i</span></th>
                        <td>40-55 kg: 800 mg</td>
                        <td>40-55 kg: 1200 mg</td>
                        <tr>
                            <td>56-75 kg: 1200 mg</td>
                            <td>56-75 kg: 2000 mg</td>
                        </tr>
                        <tr>
                            <td>76+ kg: 1600 mg</td>
                            <td>76+ kg: 2400 mg</td>
                        </tr>
                    </tr>
                    <tr>
                        <th class="uk-table-shrink">Adverse Reactions</th>
                        <td colspan="2">
                            <ul>
                                <li>Optic neuritis</li>
                            </ul>
                        </td>
                    </tr>
                </tbody>
            </table>
        </div>

        <ol>
            <li>Calculate pyrazinamide and ethambutol doses using actual body weight. Pyrazinamide and ethambutol dosage adjustment is needed in patients with estimated creatinine clearance less than 50 ml/min or those with end-stage renal disease on dialysis.</li>
        </ol>

        <p>Additional Note: Refer to current drug reference or drug package insert for a complete list of adverse drug reactions and drug interactions.</p>
        
        <p>Source: <a href="https://academic.oup.com/cid/article/63/7/e147/2196792?login=trueas">https://academic.oup.com/cid/article/63/7/e147/2196792?login=trueas</a></p>

    </div>
</div>
</body>
<script src="../assets/uikit.js" type="text/javascript"></script>
<script src="../assets/uikit-icons.js" type="text/javascript"></script>
<script src="main.js" type="text/javascript"></script>

</html>
